What's Happening?
G&H is set to demonstrate its capabilities in integrated diagnostic development at the ADLM Clinical Lab Expo 2026. The company will showcase how it supports the development and commercialization of healthcare technologies through multidisciplinary engineering,
precision optics, photonics, and ISO 13485-certified manufacturing. G&H's participation highlights its role in transforming innovative concepts into manufacturable products, with a focus on diagnostic instruments and medical devices. The company will feature the Psyros™ point-of-care diagnostic platform, developed in collaboration with Prolight Diagnostics, which is a semi-finalist in the ADLM 2026 Disruptive Technology Award Competition. G&H's expertise spans various healthcare applications, including point-of-care diagnostics, laboratory instrumentation, and life-support technologies.
Why It's Important?
G&H's involvement in the development of diagnostic technologies underscores the importance of integrated engineering and manufacturing in bringing innovative healthcare solutions to market. By providing comprehensive support from concept development to commercial manufacturing, G&H helps reduce development risks and accelerates time to market for diagnostic companies. This approach is crucial as the demand for faster, more sensitive, and automated diagnostic technologies grows. The company's work with Prolight Diagnostics on the Psyros™ platform exemplifies how strategic partnerships can drive advancements in healthcare, potentially leading to improved diagnostic capabilities and patient outcomes.
